Robert Malasek - 15 Mar 2024 Form 4 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role
Chief Financial Officer
Signature
/s/ Robert Malasek
Issuer symbol
AXIM
Transactions as of
15 Mar 2024
Net transactions value
+$2,862,250,000
Form type
4
Filing time
19 Mar 2024, 19:16:08 UTC
Previous filing
23 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXIM Convertible Note Award $2,862,250,000 +53,500 +1.6% $53500.00* 3,475,000 15 Mar 2024 Common Stock 2,675,000 $0.0200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person acquired a Convertible Note face $53,500. The Note is convertible into shares of the Issuers common stock at a price of $0.02 per share.